Drug DrugBank | All Description Patterns💬 Info on mouse-over
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
Disease ID |
1 | All subjects will receive maraviroc 300mg orally twice a day for 6 weeks | Maraviroc | [1] D06670 D06670 💬 |
CCR5 [1] CCR5 💬 |
Chemokine signaling pathway [9] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
084 [1] 84 💬 |
2 | Maraviroc | Maraviroc | [1] D06670 D06670 💬 |
CCR5 [1] CCR5 💬 |
Chemokine signaling pathway [9] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
046 [2] 46, 84 💬 |